Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 34 of 34 entries
Sorted by: Best Match Show Resources per page
Blinding in Clinical Trials: Seeing the Big Picture.

Medicina (Kaunas, Lithuania)

Monaghan TF, Agudelo CW, Rahman SN, Wein AJ, Lazar JM, Everaert K, Dmochowski RR.
PMID: 34202486
Medicina (Kaunas). 2021 Jun 24;57(7). doi: 10.3390/medicina57070647.

Blinding mitigates several sources of bias which, if left unchecked, can quantitively affect study outcomes. Blinding remains under-utilized, particularly in non-pharmaceutical clinical trials, but is often highly feasible through simple measures. Although blinding is generally viewed as an effective...

Cite
Monaghan TF, Agudelo CW, Rahman SN, et al. Blinding in Clinical Trials: Seeing the Big Picture. Medicina (Kaunas). 2021;57(7)doi: 10.3390/medicina57070647.
Monaghan, T. F., Agudelo, C. W., Rahman, S. N., Wein, A. J., Lazar, J. M., Everaert, K., & Dmochowski, R. R. (2021). Blinding in Clinical Trials: Seeing the Big Picture. Medicina (Kaunas, Lithuania), 57(7), . https://doi.org/10.3390/medicina57070647
Monaghan, Thomas F, et al. "Blinding in Clinical Trials: Seeing the Big Picture." Medicina (Kaunas, Lithuania) vol. 57,7 (2021). doi: https://doi.org/10.3390/medicina57070647
Monaghan TF, Agudelo CW, Rahman SN, Wein AJ, Lazar JM, Everaert K, Dmochowski RR. Blinding in Clinical Trials: Seeing the Big Picture. Medicina (Kaunas). 2021 Jun 24;57(7). doi: 10.3390/medicina57070647. PMID: 34202486; PMCID: PMC8308085.
Copy Download .nbib Format: NLM
BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN).

The European respiratory journal

Gaisl T, Turnbull CD, Weimann G, Unger S, Finger R, Xing C, Cistulli PA, West S, Chiang AKI, Eckert DJ, Stradling JR, Kohler M.
PMID: 34531274
Eur Respir J. 2021 Nov 18;58(5). doi: 10.1183/13993003.01937-2021. Print 2021 Nov.

No abstract available.

Cite
Gaisl T, Turnbull CD, Weimann G, et al. BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN). Eur Respir J. 2021;58(5)doi: 10.1183/13993003.01937-2021.
Gaisl, T., Turnbull, C. D., Weimann, G., Unger, S., Finger, R., Xing, C., Cistulli, P. A., West, S., Chiang, A. K. I., Eckert, D. J., Stradling, J. R., & Kohler, M. (2021). BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN). The European respiratory journal, 58(5), . https://doi.org/10.1183/13993003.01937-2021
Gaisl, Thomas, et al. "BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)." The European respiratory journal vol. 58,5 (2021). doi: https://doi.org/10.1183/13993003.01937-2021
Gaisl T, Turnbull CD, Weimann G, Unger S, Finger R, Xing C, Cistulli PA, West S, Chiang AKI, Eckert DJ, Stradling JR, Kohler M. BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN). Eur Respir J. 2021 Nov 18;58(5). doi: 10.1183/13993003.01937-2021. Print 2021 Nov. PMID: 34531274; PMCID: PMC8607905.
Copy Download .nbib Format: NLM
Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants.

Frontiers in public health

Stoehr JR, Hamidian Jahromi A, Thomason C.
PMID: 34249853
Front Public Health. 2021 Jun 24;9:702960. doi: 10.3389/fpubh.2021.702960. eCollection 2021.

No abstract available.

Cite
Stoehr JR, Hamidian Jahromi A, Thomason C. Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants. Front Public Health. 2021;9:702960doi: 10.3389/fpubh.2021.702960.
Stoehr, J. R., Hamidian Jahromi, A., & Thomason, C. (2021). Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants. Frontiers in public health, 9702960. https://doi.org/10.3389/fpubh.2021.702960
Stoehr, Jenna Rose, et al. "Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants." Frontiers in public health vol. 9 (2021): 702960. doi: https://doi.org/10.3389/fpubh.2021.702960
Stoehr JR, Hamidian Jahromi A, Thomason C. Ethical Considerations for Unblinding and Vaccinating COVID-19 Vaccine Trial Placebo Group Participants. Front Public Health. 2021 Jun 24;9:702960. doi: 10.3389/fpubh.2021.702960. eCollection 2021. PMID: 34249853; PMCID: PMC8264198.
Copy Download .nbib Format: NLM
Unanswered questions from the Evoke trial.

The Lancet. Neurology

Maher C, Littlewood C.
PMID: 32333889
Lancet Neurol. 2020 May;19(5):380. doi: 10.1016/S1474-4422(20)30110-1.

No abstract available.

Cite
Maher C, Littlewood C. Unanswered questions from the Evoke trial. Lancet Neurol. 2020;19(5):380doi: 10.1016/S1474-4422(20)30110-1.
Maher, C., & Littlewood, C. (2020). Unanswered questions from the Evoke trial. The Lancet. Neurology, 19(5), 380. https://doi.org/10.1016/S1474-4422(20)30110-1
Maher, Chris, and Littlewood, Chris. "Unanswered questions from the Evoke trial." The Lancet. Neurology vol. 19,5 (2020): 380. doi: https://doi.org/10.1016/S1474-4422(20)30110-1
Maher C, Littlewood C. Unanswered questions from the Evoke trial. Lancet Neurol. 2020 May;19(5):380. doi: 10.1016/S1474-4422(20)30110-1. PMID: 32333889.
Copy Download .nbib Format: NLM
Coronary intervention for stable angina.

BMJ (Clinical research ed.)

Timmis A, Wragg A.
PMID: 30591431
BMJ. 2018 Dec 27;363:k5351. doi: 10.1136/bmj.k5351.

No abstract available.

Cite
Timmis A, Wragg A. Coronary intervention for stable angina. BMJ. 2018;363:k5351doi: 10.1136/bmj.k5351.
Timmis, A., & Wragg, A. (2018). Coronary intervention for stable angina. BMJ (Clinical research ed.), 363k5351. https://doi.org/10.1136/bmj.k5351
Timmis, Adam, and Wragg, Andrew. "Coronary intervention for stable angina." BMJ (Clinical research ed.) vol. 363 (2018): k5351. doi: https://doi.org/10.1136/bmj.k5351
Timmis A, Wragg A. Coronary intervention for stable angina. BMJ. 2018 Dec 27;363:k5351. doi: 10.1136/bmj.k5351. PMID: 30591431.
Copy Download .nbib Format: NLM
Transcranial Direct Current Stimulation for Negative Symptoms of Schizophrenia: Why the Reader Must Choose a Clinically Relevant Outcome.

The Journal of clinical psychiatry

Andrade C.
PMID: 32023365
J Clin Psychiatry. 2020 Feb 04;81(1). doi: 10.4088/JCP.20f13256.

A recent, large, randomized controlled trial (RCT) of 10 twice-daily sessions of active vs sham transcranial direct current stimulation (tDCS), delivered across 5 consecutive days to schizophrenia patients with high negative symptom burden, found that active treatment was superior...

Cite
Andrade C. Transcranial Direct Current Stimulation for Negative Symptoms of Schizophrenia: Why the Reader Must Choose a Clinically Relevant Outcome. J Clin Psychiatry. 2020;81(1)doi: 10.4088/JCP.20f13256.
Andrade, C. (2020). Transcranial Direct Current Stimulation for Negative Symptoms of Schizophrenia: Why the Reader Must Choose a Clinically Relevant Outcome. The Journal of clinical psychiatry, 81(1), . https://doi.org/10.4088/JCP.20f13256
Andrade, Chittaranjan. "Transcranial Direct Current Stimulation for Negative Symptoms of Schizophrenia: Why the Reader Must Choose a Clinically Relevant Outcome." The Journal of clinical psychiatry vol. 81,1 (2020). doi: https://doi.org/10.4088/JCP.20f13256
Andrade C. Transcranial Direct Current Stimulation for Negative Symptoms of Schizophrenia: Why the Reader Must Choose a Clinically Relevant Outcome. J Clin Psychiatry. 2020 Feb 04;81(1). doi: 10.4088/JCP.20f13256. PMID: 32023365.
Copy Download .nbib Format: NLM
Pamrevlumab in idiopathic pulmonary fibrosis.

The Lancet. Respiratory medicine

Wells AU.
PMID: 31575507
Lancet Respir Med. 2020 Jan;8(1):2-3. doi: 10.1016/S2213-2600(19)30339-X. Epub 2019 Sep 28.

No abstract available.

Cite
Wells AU. Pamrevlumab in idiopathic pulmonary fibrosis. Lancet Respir Med. 2019;8(1):2-3doi: 10.1016/S2213-2600(19)30339-X.
Wells, A. U. (2020). Pamrevlumab in idiopathic pulmonary fibrosis. The Lancet. Respiratory medicine, 8(1), 2-3. https://doi.org/10.1016/S2213-2600(19)30339-X
Wells, Athol U. "Pamrevlumab in idiopathic pulmonary fibrosis." The Lancet. Respiratory medicine vol. 8,1 (2020): 2-3. doi: https://doi.org/10.1016/S2213-2600(19)30339-X
Wells AU. Pamrevlumab in idiopathic pulmonary fibrosis. Lancet Respir Med. 2020 Jan;8(1):2-3. doi: 10.1016/S2213-2600(19)30339-X. Epub 2019 Sep 28. PMID: 31575507.
Copy Download .nbib Format: NLM
In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months.

Annals of internal medicine

Talley NJ, Irani M.
PMID: 32422097
Ann Intern Med. 2020 May 19;172(10):JC52. doi: 10.7326/ACPJ202005190-052.

SOURCE CITATION: El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T.

Cite
Talley NJ, Irani M. In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months. Ann Intern Med. 2020;172(10):JC52doi: 10.7326/ACPJ202005190-052.
Talley, N. J., & Irani, M. (2020). In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months. Annals of internal medicine, 172(10), JC52. https://doi.org/10.7326/ACPJ202005190-052
Talley, Nicholas J, and Irani, Mudar. "In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months." Annals of internal medicine vol. 172,10 (2020): JC52. doi: https://doi.org/10.7326/ACPJ202005190-052
Talley NJ, Irani M. In irritable bowel syndrome, fecal microbiota transplantation improved symptoms at 3 months. Ann Intern Med. 2020 May 19;172(10):JC52. doi: 10.7326/ACPJ202005190-052. PMID: 32422097.
Copy Download .nbib Format: NLM
Effects of Gender Bias and Stereotypes in Surgical Training: A Randomized Clinical Trial.

JAMA surgery

Myers SP, Dasari M, Brown JB, Lumpkin ST, Neal MD, Abebe KZ, Chaumont N, Downs-Canner SM, Flanagan MR, Lee KK, Rosengart MR.
PMID: 32432669
JAMA Surg. 2020 Jul 01;155(7):552-560. doi: 10.1001/jamasurg.2020.1127.

IMPORTANCE: Factors contributing to underrepresentation of women in surgery are incompletely understood. Pro-male bias and stereotype threat appear to contribute to gender imbalance in surgery.OBJECTIVES: To evaluate the association between pro-male gender bias and career engagement and the effect...

Cite
Myers SP, Dasari M, Brown JB, et al. Effects of Gender Bias and Stereotypes in Surgical Training: A Randomized Clinical Trial. JAMA Surg. 2020;155(7):552-560doi: 10.1001/jamasurg.2020.1127.
Myers, S. P., Dasari, M., Brown, J. B., Lumpkin, S. T., Neal, M. D., Abebe, K. Z., Chaumont, N., Downs-Canner, S. M., Flanagan, M. R., Lee, K. K., & Rosengart, M. R. (2020). Effects of Gender Bias and Stereotypes in Surgical Training: A Randomized Clinical Trial. JAMA surgery, 155(7), 552-560. https://doi.org/10.1001/jamasurg.2020.1127
Myers, Sara P, et al. "Effects of Gender Bias and Stereotypes in Surgical Training: A Randomized Clinical Trial." JAMA surgery vol. 155,7 (2020): 552-560. doi: https://doi.org/10.1001/jamasurg.2020.1127
Myers SP, Dasari M, Brown JB, Lumpkin ST, Neal MD, Abebe KZ, Chaumont N, Downs-Canner SM, Flanagan MR, Lee KK, Rosengart MR. Effects of Gender Bias and Stereotypes in Surgical Training: A Randomized Clinical Trial. JAMA Surg. 2020 Jul 01;155(7):552-560. doi: 10.1001/jamasurg.2020.1127. PMID: 32432669; PMCID: PMC7240638.
Copy Download .nbib Format: NLM
Improving parents' knowledge of early signs of paediatric eye disease: A double-blind randomized controlled trial.

Clinical & experimental ophthalmology

Staffieri SE, Rees G, Sanfilippo PG, Cole S, Mackey DA, Hewitt AW.
PMID: 33058401
Clin Exp Ophthalmol. 2020 Dec;48(9):1250-1260. doi: 10.1111/ceo.13866. Epub 2020 Oct 26.

IMPORTANCE: Educating parents to recognize signs of eye disease and consult a healthcare professional is critical to timely diagnosis, intervention and outcomes.BACKGROUND: We evaluate the effectiveness of an eye-health information pamphlet on parents' level of concern and help-seeking intention...

Cite
Staffieri SE, Rees G, Sanfilippo PG, et al. Improving parents' knowledge of early signs of paediatric eye disease: A double-blind randomized controlled trial. Clin Exp Ophthalmol. 2020;48(9):1250-1260doi: 10.1111/ceo.13866.
Staffieri, S. E., Rees, G., Sanfilippo, P. G., Cole, S., Mackey, D. A., & Hewitt, A. W. (2020). Improving parents' knowledge of early signs of paediatric eye disease: A double-blind randomized controlled trial. Clinical & experimental ophthalmology, 48(9), 1250-1260. https://doi.org/10.1111/ceo.13866
Staffieri, Sandra E, et al. "Improving parents' knowledge of early signs of paediatric eye disease: A double-blind randomized controlled trial." Clinical & experimental ophthalmology vol. 48,9 (2020): 1250-1260. doi: https://doi.org/10.1111/ceo.13866
Staffieri SE, Rees G, Sanfilippo PG, Cole S, Mackey DA, Hewitt AW. Improving parents' knowledge of early signs of paediatric eye disease: A double-blind randomized controlled trial. Clin Exp Ophthalmol. 2020 Dec;48(9):1250-1260. doi: 10.1111/ceo.13866. Epub 2020 Oct 26. PMID: 33058401.
Copy Download .nbib Format: NLM
Showing 25 to 34 of 34 entries